Pfizer Enters into Exclusive Licensing Agreement with 3SBio

pfizer.com/news/press-release/press-release-detail/pfizer-enters-exclusive-licensing-agreement-3sbio

Pfizer Enters into Exclusive Licensing Agreement with 3SBio
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the…

This story appeared on pfizer.com, 2025-05-20 21:34:06.968000.
The Entire Business World on a Single Page. Free to Use →